金吾财讯 | 默沙东(MRK)盘前股价延续跌势，暂跌0.42%，报90.36美元。昨日该股大跌9.07%，报90.74美元，成交额45.83亿美元。2024年，公司销售额为642亿美元，较2023年增长7%。这接近预期的640亿美元。每股收益为7.65美元，略高于预期的7.56美元。2024年第四季度，公司营收156.2亿美元，同比增长6.77%，预期为154.5亿美元；净利润37.43亿美元，去年同期录得亏损12.26亿美元；每股收益1.48美元，预期为1.55美元。业绩指引方面，公司年度指引低于市场预期，公司预计2025年营收641亿美元-656亿美元，市场预期673.7亿美元。另外，公司还宣布暂停向中国供应HPV疫苗Gardasil，据悉这一暂停预计将至少持续到年中。摩根士丹利将默沙东目标价格从113美元下调至106美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.